The effectiveness of treatment of pulmonary tuberculosis depending on CYP3A4 genotype

Показати скорочений опис матеріалу

dc.contributor.author Poludenko, H. A. en
dc.contributor.author Antonenko, P. B. en
dc.contributor.author Rozhkovskyi, Y. V. en
dc.contributor.author Antonenko, K. A. en
dc.contributor.author Lobashova, K. G. en
dc.date.accessioned 2023-01-24T20:16:59Z
dc.date.available 2023-01-24T20:16:59Z
dc.date.issued 2022
dc.identifier.citation The effectiveness of treatment of pulmonary tuberculosis depending on CYP3A4 genotype / H. A. Poludenko, P. B. Antonenko, Y. V. Rozhkovsky et al. // Ukr. Pulmonol. J. 2022. No 30(1). P. 62–66. en
dc.identifier.uri https://repo.odmu.edu.ua:443/xmlui/handle/123456789/12010
dc.description.abstract Among the factors that can influence the course and effectiveness of the treatment of pulmonary tuberculosis (TB) the genetic characteristics of patients play an important role. It is established that cytochrome (CYP) 3A4/5 is involved in metabolism of more than 30 % of xenobiotics. Consequently, the activity of this enzyme is greatly influenced by responsible genes, such as CYP3А4. en
dc.language.iso en en
dc.subject pulmonary tuberculosis en
dc.subject anti-tuberculosis therapy en
dc.title The effectiveness of treatment of pulmonary tuberculosis depending on CYP3A4 genotype en
dc.type Article en


Долучені файли

Даний матеріал зустрічається у наступних зібраннях

Показати скорочений опис матеріалу